Allergan Investor Tries To Block $63B AbbVie Deal Over Info
Allergan was slammed Friday with a proposed securities class action in New Jersey federal court seeking to block its blockbuster merger with AbbVie until the company provides its shareholders with certain...To view the full article, register now.
Already a subscriber? Click here to view full article